Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.23
+0.26 (4.45%)
At close: May 6, 2026, 4:00 PM EDT
6.23
+0.01 (0.08%)
After-hours: May 6, 2026, 4:25 PM EDT
Lexeo Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
59
Market Cap
461.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 654.00K | -1.00M | -60.53% |
| Dec 31, 2021 | 1.66M | 1.14M | 219.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vanda Pharmaceuticals | 216.11M |
| Century Therapeutics | 109.16M |
| Assembly Biosciences | 72.30M |
| Enanta Pharmaceuticals | 66.98M |
| Invivyd | 53.43M |
| Neurogene | 925.00K |
LXEO News
- 9 days ago - Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting - GlobeNewsWire
- 5 weeks ago - Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights - GlobeNewsWire
- 2 months ago - Lexeo Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Lexeo Therapeutics Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Lexeo Therapeutics Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts
- 3 months ago - Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February - GlobeNewsWire
- 3 months ago - Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics - GlobeNewsWire